Form 6-K Galmed Pharmaceuticals For: Aug 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Galmed Pharmaceuticals terminates licensing deal, plans minority stake
August 25, 2025 8:16 AM EDTGalmed Pharmaceuticals Ltd. (NASDAQ: GLMD) terminated a licensing agreement with Entomus s.r.o. for development and commercialization of a Self-Emulsifying Drug Delivery System formulation, according to a company statement.
The pharmaceutical company ended the binding term sheet following additional due diligence and... More
Galmed Pharmaceuticals terminates licensing deal, plans minority stake
August 25, 2025 7:41 AM EDTGalmed Pharmaceuticals Ltd. (NASDAQ: GLMD) terminated a licensing agreement with Entomus s.r.o. for development and commercialization of a Self-Emulsifying Drug Delivery System formulation, according to a company statement.
The pharmaceutical company ended the binding term sheet following additional due diligence and... More



